Search

everythinglearnresearchcommunity

for

Search:↓

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Progesterone affects GABA_A receptor function by altering δ subunit levels.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Mutations in certain receptors can cause diseases and offer new treatment options.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Higher levels of the DP2 receptor may lead to hair loss.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

New progesterone-based compounds can block male hormones.

Neurosteroids help control dopamine responses in the brain.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

The new method showed that endometriotic tissue has lower estrogen receptor levels but similar progesterone levels compared to normal endometrium, with both following a similar cycle.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Androgen receptors help prostate cancer cells grow and resist drugs.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.